Publications
Population pharmacokinetic-pharmacodynamic analysis of benznidazole monotherapy and combination therapy with fosravuconazole in chronic Chagas disease (BENDITA)
Assmus, F., Cruz, C., Watson, J., White, N., Adehin, A., Hoglund, R., Blum de Oliveira, B., Barreira, F., Scandale, I., & Tarning, J. (2025). PLoS Neglected Tropical Diseases, 19(9), e0013522 - e0013522.
Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: a secondary analysis of individual patient data from two proof-of-concept trials
Watson, J., Cruz, C., Barreira, F., Forsyth, C., Schijman, A., Peploe, R., Assmus, F., Naylor, C., Lee, J., Mehra, S., Tarning, J., Torrico, F., Gascon, J., Ortiz, L., Ribeiro, I., Sosa-Estani, S., Tipple, C., Hugonnet, S., Guérin, P., … Asada, M. (2025). The Lancet Microbe, 101156.
Phase 2 pilot trial to optimise pharmacometric evaluations in Chagas disease (CHARM: CHAgas disease PharMacometrics)
Cruz, C., Watson, J., Molina Romero, I., & White, N. (2024). Wellcome Open Research, 9, 342.
Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: an individual patient data meta-analysis of two proof of concept trials
Watson, J., Cruz, C., Barreira, F., Forsyth, C., Schijman, A., Peploe, R., Assmus, F., Naylor, C., Lee, J., Mehra, S., Tarning, J., Torrico, F., Gascon, J., Ortiz, L., Ribeiro, I., Sosa-Estani, S., Tipple, C., Hugonnet, S., Guérin, P., … White, N. (2024). In medRxiv.
The Chagas disease study landscape: A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data platform
Maguire, B., Dahal, P., Rashan, S., Ngu, R., Boon, A., Forsyth, C., Strub-Wourgraft, N., Chatelain, E., Barreira, F., Sosa-Estani, S., & Guérin, P. (2021). PLOS Neglected Tropical Diseases, 15(8), e0009697.